Download - Canadian Alcohol and Drug Use Monitoring Survey_ Summary of Results for 2012 - Health Canada
-
8/9/2019 Canadian Alcohol and Drug Use Monitoring Survey_ Summary of Results for 2012 - Health Canada
1/7
2 /8 /2015 Canad ia n A l coho l a n d
D r ug U s e Mo n it or in g
Survey:
Summa ry o f Resu lt s
fo r 2012
-
Hea lt h Canada
Haal lh S a i r i t é I
Iil
C E l | ‘ l i E | t : F £ | i
C a n a d a C a n a d a
H o m e > Hea l t h Con c e r n s > Drug Preven t ion &
Treatment >
D rug a nd A l c o h o l
Use
Sta t i s t i cs
Health Concerns
Summary
of
Results for 2 0 1 2
-
I n t r o duc t i o n
-
De ta i l ed
Tables
-
Cannab i s
Use
- Othe r Illicit
Drug Use
- Use a nd Abuse o f P s yc h o a c t iv e P h a rm a c e u tic a l
D r ugs
- Ha rms
Re l a ted
to Illicit Drug Use
- A l c o h o l
P re va l ence
o f A l c o h o l Use
Low- r i sk A l c o h o l Use
Ha rms Re l a ted
to
Othe r
People 's
A l c o h o l
Use
- De f i n i t i o n s
-
Re f e r e n c e I n f o rma t i o n
Introduction
The Ca n a d i a n
A l c o h o l
a n d
D rug Use
M o n ito rin g S u rv e y
( C ADUMS ) is
a n
a n nu a l g en e ra l popu l a t i on
s u r v e y
o f
a l c o h o l
a n d illicit
d rug
use a m o n g
Cana d i a n s aged 15
ye a r s a nd o l d e r that ran
f r om
2 0 0 8
t h r o ugh
2 0 1 2 . De r i ved f r om a n d similar to th e Ca n a d i a n Add i c t i o n
S u r v e y
( C AS ) o f 2 0 0 4 , CADUMS
was d e sig n ed to
p rov i de
de ta i l ed
n a t i o n a l
an d p ro v i n c i a l es t ima t es
o f
a l c o h o l - a n d d r ug - r e l a t ed
beha v i o u r s
a n d o u t c ome s . The f o l l ow ing
r epo r t presen t s r es u lts fr om
th e fifth a n d f i n a l
a n n u a l
CADUMS da ta c o l l e c t i o n ,
which
c omme n c e d in Fe bru a ry 2 0 1 2 . The Ca n a d i a n T oba c co , A lc o h o l a n d
D r ugs
Su r v e y
( C TADS )
wil l
r ep l ace
C A D UM S ;
it
was
l a u n c he d
in
2 0 1 3
an d
a sks ke y
ques t i ons
a b o u t
a l c o h o l an d
d rug
use on
a b ienn i a l
bas i s .
The
resu l t s
for
2 0 1 2 a re based on t e l e p hone i n t e r v i ews
with
1 1 ,0 90 re s po n d e n ts a cro ss a ll 10
p ro v i n ce s , which r e pr e s e n t 2 7 ,767 ,8 5 5
Ca n a d i a n
r es i den t s aged 15 yea r s a nd o l de r .
The
c u r r e n t
S umma r y o f Resu l t s
for
2 0 1 2 presen t s da t a
f r om
th e l a t e s t CADUMS
with
c o m p ar is o n s to CADUMS
2 0 1 1 a n d CAS 2 0 0 4 , to identify a n y
c h a n g e s
that ha v e t aken p lace in th e pa st 8 ye a r s . A
d i s c us s i o n o f
th e r es u lts fr om CADUMS
2 0 1 2 ,
d e ta i le d ta b le s
a n d
s ome de f i n i t i o n s
used in
th i s
r epo r t
a re
a lso p ro v i d ed .
Ma i n
indicators, overall,
C A S
2004, C A D U M S
2008-2012
Cannabis U se
C a n n a b i s -
l if e t i m e
4 4 . 5
4 3 . 9 4 2 . 4
4 1 . 5 39.4E| 4 1 . 5
C a n n a b i s - p a s t - y e a r 1 4 . 1
11.4El 1 0 . 6 l E l 1 0 . 7 | E l
9 . 1EE l 10.2 | I l
9 O a r n ; 7 c ? u t 2 c i | _ f ’ A ve r a g e
a g e of initiation
1 5 .6 y e a rs 1 5 .5 y ea rs 1 5 .6 y e a rs 1 5 .7 y e a rs 1 5 .6 y e a rs 16.1 yearsli]
Other Illicit
drug
u se
in past
year
C o c a i n e / C r a c k 1 . 9 1 . 6 1 . 2 l E l
o . 7 l G i 0.9lElTl
1 . 1 l E l
Q .
| |
| _ |
| _ | | _ |
| ‘I
ht tp:/ /www.hc-sc.gc.ca /hc-ps/d rugs-drogues/s ta t /_2012/sum mary -som maire-eng.php
http://www.hc-sc.gc.ca/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/index-eng.phphttp://www.hc-sc.gc.ca/hc-ps/index-eng.phphttp://www.hc-sc.gc.ca/index-eng.php
-
8/9/2019 Canadian Alcohol and Drug Use Monitoring Survey_ Summary of Results for 2012 - Health Canada
2/7
2 /8 /2015 Canad ia n A l coho l a n d
D ru g U s e Mo n ito rin g
Survey:
Summa ry o f Resu lt s
fo r 2012
-
Hea lt h Canada
0.4 ‘ 4 1 0.5 ‘ 4 1
peed
Ha l lu c in o g e n s ( ex c lu d i n g
sa l v i a )
Ha l l u c i n o g e n s ( in c lu d in g s a lv ia )
Ecs t a s y
Sa lv ia
Me t h amph e t am i n e / C r y s t a l
me t h
A n y
6 d r u g s a ( h a l l u c i n o g en s
exc l .
s a l v i a )
A n y 5 d r u g s
b
( h a l l u c i n o g en s exc l .
s a l v i a )
A n y 6 d r u g s a ( h a l l u c i n o g en s
i nc l .
s a l v i a )
A n y
5
d r u g s b ( h a l l u c i n o g en s
i nc l .
s a l v i a )
Drug related harms in
past
year
A n y
d ru g h a rm
to se l f
a m o n g
use r s
of
a ny d ru g
A n y
d ru g h a rm
to se l f
a m o n g
total
popu l a t i on
Alcohol
u se
Li f e t ime
Use
Pas t 1 2
mon t h
Use
A ve r a g e
a g e of initiation
for y ou t h
15
to
2 4
yea r s
0.8
0.7
1 .1
0.2
14.5
3.0
17.5
2.8
92.8
79.3
1 .1
‘L 1
l - l . I .
1.4
IZ-
_'|
12.1
3.9
21.7
2.7
90 . 2 1 - I
77.3
0
.
7 ‘L
0.9
0.9'l.l 1 : 1 .1
0
.9
‘L
5
5
11.0
Y ’ 1
2.0
11.1
2.11:
88.6
H
76.5
H
0.7
0 3 Li
IZ-
_'|
11.0.i
1 . 8 1 - I
11.1
2.0
17.0
2.1
88.91-i
77.0
0.5 ‘ I 4 1
0 .6 ‘L l
0
.9 ‘L
0 . 7 ‘L l
5
5
9.4 =
1_7
9.4 =
1.9
17.6
89.7
78.0
5
0.9
‘ 4 1
1 .1 ‘L l
0.6 ‘L l
5
5
10.6
‘I’
2.0
‘I ’
10.6
2.0
16.6
2.0'34i
91.0
78.4
1 5 .6 y e a rs 1 5.6 y ea rs
1 5 . 9
yea r s
1 5 . 9
yea r s
16.0
y e a rs 1 6.2 y e a rs
T
2011 Low-risk drinking guidelines (LRDG) - past 12 months
Exceeds
LRDG
c h r o n i c
Exceeds
LRDG a cu t e
Exceeds
LRDG c h r o n i c - a m o n g
d r i nke r s
Exceeds
LRDG a cu t e - a m o n g d r in ke rs
l ‘ - l
S am p le s iz e
I I nd i ca tes
that
t h e d i ff e re n c e between 2008 a n d 2004 is
s tat is t ica
M i
I nd i ca tes that t h e d i ff e re n c e between 2009
a n d
2004 is s tat is t ica
j-i
I nd i ca tes that t h e d i ff e re n c e
between 2010 a n d 2004 is
s tat is t ica
Ind i ca tes
that
t h e d i ff e re n c e between 2 0 1 1 a n d 2004 is
s tat is t ica
|
I nd i ca tes that t h e d i ff e re n c e
between
2012
a n d 2004
is s tat is t ica
: l:
I nd i ca tes that t h e d i ff e re n c e
between 2008 a n d 2009 is
s tat is t ica
14.3
10.2
18.0
12.9
15.0
10.9
19.8
14.3
14.5
11.7
19.1
15.5
y
s ign i f i c an t .
y s ign i f i c an t .
y s ign i f i c an t .
y s ign i f i c an t .
y s ign i f i c an t .
y
s ign i f i c an t .
The re
a re
no
s t a t is t ic a l l y s i g n i fi c a n t d i f fe r e n c e s
between 2 0 1 0
a n d
2 0 0 9 in
th is table.
= I nd i ca tes that t h e d i ff e re n c e
between 2 0 1 1 a n d 2010
is s tat is t ica
y
s ign i f i c an t .
: l : | =
I nd i ca tes that t h e d i ff e re n c e
between
2012
a n d
2 0 1 1 is s tat is t ica y s ign i f i c an t .
5 Es t ima t e supp ressed d u e
to h ig h samp l i ng
var iab i l i t y
L 1
E s ti m a te q ua li fi ed d u e
to h ig h
samp l i ng
var iab i l i t y ; i n te rp re t
w it h c a u ti o n
--
No
c ompa r a bl e e s t im a t e s .
14.5
10.5
19.1
13.8
14.4
10.1
18.7
13.1
14.4
9.9
18.6
12.8
l- l. i -
In 2008, th e
l i s t
o f s u b st a n c e s
u n d e r
ha l l u c i n ogens
i n c l u ded s alv ia a n d m a gic mus h r o om s ;
as
a r su t
th e
es t ima t e is
n o t compa rab le
to
2004,
2009-2012.
.3 Cann ab i s , c o c a i n e / c r a c k , speed ,
e c s ta s y , h a l lu c i n o g e n s ,
he ro i n
|; i Coca i n e / c r a c k , speed ,
e c s ta s y , h a l lu c i n o g e n s ,
he ro i n
Detailed
Tables
- Table 1 : Ma in 2 0 1 2 CADUMS i n d i ca t o rs by sex an d a ge
- D r ugs
- Table 2 :
Ma in
2 0 1 2 CADUMS i n d i ca t o rs by
p r o v i n c e - D r ugs
- Table 3:
Preva l ence
o f d r ug use a nd
ha rms ,
to ta l p o pu la t io n , CAS 2 0 0 4 , CADUMS 2 0 0 8
http:/ /www.hc-sc.gc.ca /hc-ps/d rugs-drogues/s ta t /_2012/summary-sommaire-eng.php
http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t1http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t2
-
8/9/2019 Canadian Alcohol and Drug Use Monitoring Survey_ Summary of Results for 2012 - Health Canada
3/7
2 /8 /2015 Canad ia n A l coho l a n d
D ru g U s e Mo n ito rin g
Survey:
Summa ry o f Resu lt s
fo r 2012
-
Hea lt h Canada
2 0 1 2
- Table
4:
Preva l ence
o f
drug
use a nd
ha rms , by
age
g r oup ,
CAS 2 0 0 4 , CADUMS
2 0 0 8
-
2 0 1 2
- Table
5 : Preva l ence
o f drug use a nd
ha rms ,
by sex, CAS 2 0 0 4 , CADUMS 2 0 0 8
-
2 0 1 2
- Table
6:
Ma in 2 0 1 2 CADUMS i n d i ca t o rs by sex an d
a ge
A l c o h o l
- Table
7: Ma in
2 0 1 2
CADUMS
i n d i ca t o rs
by p r o v i n c e
A l c o h o l
- Table
8 :
Preva l ence
o f a l c o h o l use a nd
ex ceed i n g LRDG,
to ta l p o pu la t io n , CAS
2 0 0 4 ,
CADUMS 2 0 0 8 - 2 0 1 2
- Table
9:
Preva l ence
o f a l c o h o l use a nd
ex ceed i n g LRDG,
by a g e , CAS 2 0 0 4 an d CADUMS
2 0 0 8 2 0 1 2
-
Table
1 0 :
Preva l ence
o f
a l c o h o l
use
and
ex ceed i n g
LRDG,
by
sex ,
CAS
2 0 0 4
a nd
CADUMS
2 0 0 8 - 2 0 1 2
All
reported
increases
and
decreases
in
the text below are statistically significant
changes.
Th e words
statisticallysignificant will not
be
used s o a s to
allow
for more
readable text.
C a n n a b i s U se
The
p re va l e n ce
o f p as t-y e a r c annab i s use a m o n g
Cana d i a n s aged 15
ye a r s an d o l d e r wa s 1 0 . 2
in
2 0 1 2 ,
u n c h a n g e d
f ro m 9.1 in 2 0 1 1 , bu t
lo w er th a n
in 2 0 0 4 (14.1 ). The re was an i n c rease in
pa s t - y e a r
c annab i s
use a m o n g
adu l t s aged
2 5 y e a r s an d o l d e r to
8 .4 in 2 0 1 2 fro m 6.7 in
2 0 1 1 ,
a n d
no
c h a n g e
f rom
2 0 1 1
a m o n g
y o u t h
aged
15
to
2 4
y ea rs . H o we ve r, th e
p re va l e n ce o f p a s t - y e a r
c annab i s
use a m o n g
y o u t h ( 2 0 . 3 ) r ema i n s h i g h e r t h an that o f adu l t s (8.4 ).
You ths
initiated
use
o f c annab i s
a t
an o l d e r a ge in
2 0 1 2 t h a n
in 2011(16.1 ve r s us 15 .6 yea r s ) .
The
p re va l e n ce
o f
p a s t - y e a r
c annab i s use in 2 0 1 2 was
lo w er th a n
in 2 00 4 a mo ng
ma l e s
(13 .7
ve r s us 1 8 . 2 ) , f em a l e s
(7.0
ve r s us 1 0 . 2 ) a n d y o u t h aged 15 to
24
ye a r s ( 2 0 . 3 ve r s us
37 .0 ) , with
th e
p re va l e n ce
a m o n g
ma l e s r em a i n in g tw ic e
as h igh as that o f
f em a l e s
(13 .7
ve r s us 7.0 ,
r e spec t i v e l y ) .
Preva l ence
a m o n g
adu l t s
aged 2 5 ye a r s a nd o l d e r was u n c h a n g e d
be tween 2 0 1 2 a n d 2 0 0 4 .
Prov i nc i a l
p re va l e n ce
o f
p a s t - y e a r
c annab i s use r a n ged f ro m 8 .5 in New B ru n swic k to 1 3.8 in
Bri t ish Co l umb i a . Th e re we re no yea r—to—year c h a n g e s in p ro v i n c i a l ra tes o f c annab i s use . Each
p rov i n ce ' s pa s t - y e a r
c annab i s
p re va l e n ce
was
c ompa r e d
with
th e a v e r a g e
p re va l e n ce
for
th e
n i ne
r em a i n in g p ro v in c e s .
Of
th e se , o n ly Br it is h Co lumb i a
shows h i g h e r th a n a ve ra ge
p re va l e n ce .
Other Illicit Drug
Use
In
2 0 1 2 , pa s t - y e a r use o f
th e m os t c om m o n l y r epo r t ed illicit d r u g s
after
c annab i s was es t ima t e d to
be a b o u t
1 for
ea c h
( e c s t a s y (0.6 ),
h a llu c in o g e ns in c lu d in g s a lv ia
(1.1 ) a nd c o c a i n e
o r
c r a c k
(1.1 )).
Pas t - ye a r
use
o f spee d , m e th a m ph e ta m in e o r he ro i n
is
n o t r epo r t ab l e . Th e re we re no
c h a n g e s
in
p re va l e n ce
o f
a n y o f
t h e s e d r u g s individually,
be tween 2 0 1 2
a n d 2 0 1 1
o r be tween 2 0 1 2
a n d 2 0 04 .
Use o f a t le as t
on e
o f five illicit d r u g s exc l ud i ng c annab i s [c oc a in e o r c ra c k, s pe ed , e c s t a s y ,
h a l l u c i n o gen s (in c lu d in g s a lv ia ) o r h e ro in ]
was
r epo r t ed
by
2 . 0 o f
Cana d i a n s
a n d
is
n o t
different
f rom 2 0 1 1 (1.9 ). The r epo r t ed ra te o f such use by
ma l e s
(3.1 ) was a lm o s t triple that r epo r t ed
by
f em a l e s
(1.1 ),
whi le th e
ra te
o f
use
by y o u t h (6.5 )
was
five t im e s h ig h er th an
that
r epo r t ed
by
adu l t s
(1.2 ). R a tes a re n o t c o m p a ra ble
to
2 0 04 be ca use
sa l v i a
was n o t in c lu d e d in th e
CAS .
Users
o f illicit d ru g s we re
asked
h ow e as y it
wou l d
be
for
t h em
to g e t that spec i f i c d rug if t h e y
wan ted s ome
now .
M o st u se rs
o f
c annab i s (84.5 )
an d
c o c a i n e (77.8 ) sa id
it
would
be
e as y o r
ve r y
e a sy to g e t.
Resu l t s for o t h e r d rugs a re n o t
repor tab le
d ue
to
lo w n u m be rs a nd
s m a ll s a m ple
s i ze .
U se a n d Ab u s e of Psychoactive
Pharmaceutical
D r u g s
ht tp: / /www.hc-sc.gc.ca /hc-ps/d rugs-drogues/s ta t /_2012/summary-sommaire-eng.php
http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t3http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t7http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t5http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t9http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t6http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t10http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t8http://www.hc-sc.gc.ca/hc-ps/drugs-drogues/stat/_2012/tables-tableaux-eng.php#t4
-
8/9/2019 Canadian Alcohol and Drug Use Monitoring Survey_ Summary of Results for 2012 - Health Canada
4/7
2 /8 /2015 Canad ia n A l coho l a n d
D ru g U s e Mo n ito rin g
Survey:
Summa ry o f Resu lt s
fo r 2012
-
Hea lt h Canada
CADUMS i n c l u de s qu e s tio n s r e la t in g to th e abuse o f th re e c l asses
o f
p s y c h o a c tiv e p h a rm a c e u t ic a l
d rugs . The
t h ree c l asses
o f d r u g s
a re : op io id
pain r e l i eve r s , ( s uch as Pe r c o d a n® ,
Dem e r o l ®
an d
OxyContin®); s t imu l an t s , ( s uch as Ritalin®, Con c e r t a® ,
Adde r a l l ®
a nd Dexedrine®); an d
t r anqu i l l i ze r s a nd
seda t i v e s ,
( s uch
as Valium®,
Ativan® a nd
Xanax®) . W h ile th e se
d rugs a re
presc r ibed for t h e r apeu t i c
purposes ,
t h e y h a v e th e po t e n t i a l to be abused d ue
to
their p s y c h o a c t i v e
p rope r t i e s .
To
p rov i de
a base l i ne on o ve r a l l use,
i n c l ud i ng
t h e r apeu t i c use an d
abuse ,
r e sponde n t s
were asked whe t h e r o r n o t
t h e y had
used op io id pain r e l i eve r s ,
s t imu l an t s ,
o r s e d a tiv e s .
A mo n g
t h o s e who had used t h e s e
d r ugs ,
further
ques t i ons were a ske d to de t e rm i n e
whe t h e r th e d r u g s
were used
for
r e a s o n s
o t h e r
t h an
for
presc r ibed t h e r apeu t i c purposes .
A l t h o ugh th e o ve r a l l
ra te o f
p s y c h o a c tiv e p h a rm a c e u t ic a l
use a m o n g
Cana d i a n s aged 15
y e a r s
and
o l d e r wa s u n c h a n g e d be tween 2 0 1 2 (24.1 ) a nd 2 0 1 1 (22.9 ), th e ra te o f such use a m o n g you t h
in c re a se d to 24.7 in 2 0 1 2 f r om 17.6 in 2 0 1 1 . Use o f p s y c h o a c tiv e p h a rm a c e u t ic a ls wa s similar
be tween y o u t h aged 15 to
2 4 ye a r s an d
adu l t s aged
2 5 ye a r s a n d o l d e r
( 23 .9 ) wh ile p re v a le n c e
was h i g h e r a m o n g
f ema l e s
(26.7 ) t h an
ma l e s
(21.3 ).
In
2 0 1 2 ,
o f Cana d i a n s aged 15 ye a r s a n d
o l d e r who
i n d i c a t e d t h e y
had
used a psychoa c t i v e
pha rmaceu t i c a l
in th e pa st
y e a r ,
6.3 (or
41 0 , 0 0 0 Cana d i a n s , co r r e spond i n g to
1 . 5 o f th e t o t a l
p opu l a t i o n ) r epo r t ed t h e y abused such a d rug
( i . e .
used it
for
th e expe r i e n ce , th e f ee l i ng it
c au se d, to g e t h igh o r
for
othe r r e a s ons ) . These ra tes
o f
abuse
a re
h ig h e r th a n in
2 0 1 1 ,
when
3 .2
o f use r s
( c o r r e spond i n g
to
0 .7
o f th e to ta l p o pu la t io n ) r epo r t ed t h e y ha d abused su c h
a
d r u g .
H i g h e r
ra tes
o f
a bu se we re
a lso obse r v e d
a mo n g m a le use rs
in
2 0 1 2 ,
with 7.8
( c o r r e spond i n g
to
1 .6
o f
th e
ma l e popu l a t i o n )
a bu sin g th e se
d r u g s
c om pa re d to
2 0 1 1
ra tes
o f
3 .1
a n d 0 .6 , r e sp e c tiv e ly . The re was
no
c h a n g e in
p re va l e n ce
a m o n g
adu l t s
aged 2 5 ye a r s a nd
o l de r ,
wh i le
c h a n g e s a m o n g y o u t h a nd fe m a le s c a nn o t be es t ima t e d because
their
ra tes
for 2 0 1 1
a re
n o t r epo r t ab l e .
Opioid
Pa in
Relievers
Of
th e
t h ree
ca t e go r i e s o f pha rmaceu t i c a l s ,
op io id
pain r e l i e ve rs were th e m os t c om m o n l y used in
2 0 1 2 ,
with
o n e
in s ix (16.9 ) Cana d i a n s aged 15 ye a r s
a nd o l d e r
r epo r t i ng
their use
in th e 12
m o nth s pre ce din g th e
s u r v e y .
Th e re we re
no c h a n g e s
in th e
p re va l e n ce
o f
p a s t - y e a r
use o f
op io id
pain r e l i e ve rs c ompa r e d
with
2 0 1 1 ,
n o r were t he re a n y
within-year
d i f f e r en c es , by
sex
o r
a ge
g roup .
A mo n g
users
o f
op io id
pain r e l i eve r s ,
5 . 2
(or 243 , 0 00
C a n a d i a n s r ep re s e n tin g 0 .9
o f th e t o t a l
p opu l a t i o n ) r epo r t ed
abusing
t h em . The
c h a n g e
f rom
2 0 1 1
c a n n o t be es t ima t e d because th e
ra te
for 2 0 1 1
is n o t r epo r t ab l e .
A mo n g a d u l t use r s o f
op io id pain
r e l i eve r s ,
3 .1 ( co r respond i ng to
0 . 5 o f th e to ta l a d u lt p op ula tio n ) abused such d r ugs , an i n c rease o v e r th e 2 0 1 1
ra tes
( 1 . 3
a m o n g u se rs a nd
0 . 2 wi th in th e
t o ta l p o p u la t io n ) .
A
ques t i on
was a d d e d in 2 0 1 2 to
de t e rm i n e
whe t h e r use rs o f
op io id
pain r e l i e ve rs
ta m p e re d w ith
their
med i c a t i o n pr i o r to use : D u rin g th e pa st12 mon t h s d id y o u
e ve r ta m pe r
with a pain reliever
p ro du c t be fore
ta kin g it, for
examp l e ,
c rush t ab le t s
to s wa llo w, s n o rt o r in je c t?
When tam pe r in g
was a d d e d to th e ex i s t i ng definition o f abuse , it d id n o t r e su l t in a n y c h a n g e in pain reliever abuse
c ompa r e d with
2 0 1 1 ,
n o r were t he re a n y d i f f e r en c es in th e 2 0 1 2 resu l t s be twe en th e
ex i s t i ng
definition
o f
abuse
an d
that definition
w ith tam p e r in g
a d d e d .
Stimulants
The re was an i n c rease in th e use o f s tim u l a n ts be tween 2 0 1 2 (1.5 ) a nd 2 0 1 1 (0.9 ) a m o n g
Cana d i a n s aged 15
ye a r s a n d o l de r .
P re va l ence
a m o n g
y o u t h aged 15 to
2 4 ye a r s
(4.9 )
wa s
h i g h e r t h an a m o n g
adu l t s aged
2 5 ye a r s an d o l d e r (0.9 ), whi le
t he re
wa s
no
d i f f e r ence in
p re va l e n ce be tw ee n m a le s (1.9 ) a n d f ema l e s (1.1 ). Th e re we re no c h an g es be tw ee n 2 0 1 2 a nd
2 0 1 1
in th e pre va le nc e o f
pa s t - y e a r use
o f
s t imu l an t s by sex
o r
a ge
g roup .
For ty
pe r cen t
(40.1 ) o f peop le who used s t imu l an t s (or 1 68 ,0 0 0 C a n a d ia n s,
r ep resen t i ng
0 .6 o f
th e
to ta l p o pu la t io n ) r epo r t ed abusing
t h em .
Th is ra te
is u n c h a n g e d f rom
2 0 1 1
when 27.4
o f
ht tp: / /www.hc-sc.gc.ca /hc-ps/d rugs-drogues/s ta t /_2012/summary-sommaire-eng.php
-
8/9/2019 Canadian Alcohol and Drug Use Monitoring Survey_ Summary of Results for 2012 - Health Canada
5/7
2 /8 /2015 Canad ia n A l coho l a n d
D ru g U s e Mo n ito rin g
Survey:
Summa ry o f Resu lt s
fo r 2012
-
Hea lt h Canada
use r s
r ep o rte d a b us in g s t imu l an t s . The 2 0 1 2 ra tes o f abuse
for
th e t o t a l popu l a t i on a n d a m o n g
u se rs by sex
o r
a ge g r oup ,
c a n n o t
be
c om pa re d to
th e 2 0 1 1
ra tes
because th e 2 0 1 1
ra tes
a re n o t
r epo r t ab l e .
Sedafives
The re
were no c h a n g e s in
th e
p re va l e n ce
o f p as t- y e a r use o f seda t i v e s
(10.2 )
by
Cana d i a n s
aged 15 ye a r s a nd o l de r . The re wa s h i g h e r
p r e va l e n ce
o f such
use
by f ema l e s (12.8 ) c ompa r e d
with ma l e s
(7.5 ),
an d no d i f f e r en c e be tween y o u t h a n d adu l t s .
Abuse
o f s e d a tiv e s, measu r e d by
use
for
th e
expe r i e n ce ,
th e
fe e lin g th e y
c a u s e
o r
to
g e t
h i g h ,
is
n o t
r epo r t ab l e
d ue
to th e
lo w
numbe r s o f users a n d s m all s am ple s ize.
Other
The
abuse
o f d e xtro m e t h o rp h a n , an a c tiv e in g re d ie n t f o u n d in ma n y over-the-counter c o u g h -
supp re ssan t
co ld
med i c i n e s ,
is n o t r epo r t ab l e d ue to th e lo w n u m be rs o f
use r s
a nd s m all s am ple
s i ze .
Harms
Related
to
Illicit D r u g U se
In 2 0 1 2 ,
2 . 0
o f
Cana d i a n s aged 15
ye a r s a n d o l d e r r epo r t ed
expe r i enc i ng
a t le as t o n e ha rm in
th e pa st
y e a r
d ue
to
their
illicit
drug
use ,
a
ra te u nc ha n ge d
f r om
2 0 1 1
(1.8 )
an d
f r om
2 0 0 4
(2.8 ).
The
p re va l e n ce
o f
r epo r t ed ha rm
d ue
to
their own
drug
use was
four t im e s h ig he r
a m o n g
y o u t h aged 15 to
2 4
ye a r s (5.5 )
th a n a d u lts
aged 2 5 ye a r s an d o l d e r (1.4 ). A m o n g c u r r e n t
use r s
o f a ny d ru g, i n c l ud i ng abuse o f p sy c h o a c tiv e p h ar m a c eu tic a ls s i n ce
2 0 0 8 ,
th e re po rte d ra te
o f p as t-y e a r ha rm ha s n o t c ha ng ed s in ce 2 0 04,
with
app r ox ima t e l y o n e in
s ix (16.6 )
use r s
r epo r t i ng
hav i n g
expe r i enced
so me h arm in th e pa st year d ue to
their
d rug use .
Alcohol
Prevalence of Alcohol U se
In 2 0 1 2 ,
78 .4 o f Cana d i a n s
repo r t ed
d r i nk i ng
a l c o h o l in
th e pa st y e a r , a
ra te similar
to
that
r epo r t ed
in
2 0 1 1
(78.0 ).
Th ere wa s,
howeve r ,
a
de c r e ase
in
pa s t - y e a r
a l c o h o l
use
a m o n g
y o u t h
15 to
2 4
ye a r s
o f a ge
c om pa re d to CAS in 2 0 0 4 , f ro m 8 2 .9 to 70 . 0 in 2 0 1 2 . S im i l a r to p rev i ous
yea r s , in
2 0 1 2 , a
h i g h e r
pe r c e n t age o f
ma l e s
t han
f em a l e s
r epo r t ed pa s t - y e a r a l c o h o l use ( 82 .7
ve r s us 74.4 ,
r e spec t i v e l y )
w hile th e
p re va l e n ce
o f past-year d r i nk i ng a m o n g adu l t s aged 2 5
ye a r s an d o l d e r
(80.0 )
wa s
h ig h e r th a n
a m o n g
y o u t h (70.0 ).
Prov i nc i a l
ra tes
o f
cu r r e n t
d r i nk i ng r a n ged
f ro m 72 .3
in Nova
S c otia to 8 2 . 1
in
Quebec . Each
p rov i n ce ' s
pa s t - y e a r
a l c o h o l
p re va l e n ce
was c ompa r e d
with
th e a ve ra g e
for
th e n ine
r ema i n i n g
p rov i n ces .
Th ree
p ro v i n ce s
ha d
l owe r th a n a ve ra ge p re va l e n ce (Nova Sco t i a ,
New
Brunsw i ck
(73.8 )
a nd Prin ce E dwa rd I s l and (74.0 ))
whi le th e p re va l e n ce
o f p as t-y e a r a l c o h o l use in
Quebec wa s h i g h e r t h an
a v e r a g e .
Preva l ence
o f p as t- y e a r
a l c o h o l
use s i n ce 2 0 1 1
was u n c h a n g e d
for a ll
p rov i n ces .
Low-risk
Alcohol
U se
In No v em b e r 2 0 1 1 , th e Ca n a d i a n fe d e r a l, p ro v in c i a l, a nd territorial
hea l t h
m in i s t e rs r e ce i ved
Canada ' s
Low-Risk
A l c o h o l
Dr i nk i ng
Guidelinesl
(LRDG) , which
c o n s i s t o f five gu i d e l i n e s a nd
a
se r ies o f t ips .
Gu i d e l i n e s
a nd 2 , an d acu t e an d c h r on i c
e f f e c t s , a re
exp la i ned in th e de f i n i t i o n s
sec t i on
be low. Pe ople wh o d r in k w ith in th e l ow- r i sk a l c o h o l d r i nk i ng
gu i d e l i n e s c o n s ume no mo r e
th a n th e re co m m en de d quan t i t y o f a l c o h o l wi th in th e
n umbe r
o f d a y s spec i f i ed ,
whe reas
t hose who
e xc ee d th e gu i d e l i n e s c o n s ume mo r e a l c o h o l t h an r e c ommende d wi th in th e s t a t ed
t i me f r ame .
The bas i s o f th e
LRDG is
re po r te d a lc o h o l
con sump t i o n
in th e
7 d a y s
pr i o r to
th e s u r v e y . Because
th is in fo rm a t io n is ava i l ab l e
for
CAS 2 0 0 4 an d ea c h
y e a r
o f CADUMS ( 2 0 0 8 - 2 0 1 2 ) , e x c e e d a n c e o f
ht tp: / /www.hc-sc.gc.ca /hc-ps/d rugs-drogues/s ta t /_2012/summary-sommaire-eng.php
-
8/9/2019 Canadian Alcohol and Drug Use Monitoring Survey_ Summary of Results for 2012 - Health Canada
6/7
-
8/9/2019 Canadian Alcohol and Drug Use Monitoring Survey_ Summary of Results for 2012 - Health Canada
7/7
2 /8 /2015 Canad ia n A l coho l a n d
D ru g U s e Mo n ito rin g
Survey:
Summa ry o f Resu lt s
fo r 2012
-
Hea lt h Canada
Repo r ted use in th e 1 2 m o nth s pre ce din g th e i n t e r v i ew.
Prevalence
The
p ropo r t i on
o f a g r oup o r p o pu la t io n
repo r t i ng
th e i n d i ca t ed beha v i o u r o r
o u t c ome ,
u sua l l y
exp ressed as
a pe r c e n t age .
Reference Information
The Ca n a d i a n A l c o h o l an d D rug Use
M o n ito rin g S u rv e y
( C ADUMS )
is
a n
a n n u a l
ge ne r a l popu l a t i on
su r ve y o f
a l c o h o l
a n d
illicit
d rug
use
a m o n g
Cana d i a n s
aged
15
an d
o l d e r ,
sponso r e d
by
Hea l t h
Ca n a d a . It was de ve l oped in
c o l l abo r a t i o n
with th e
Cen t r e for
Add i c t i o n s
a nd
Men t a l Hea l t h
( CAMH ) , th e Cen t r e
for
Add i c t i o n Rese a r c h
-
Bri t ish Co lumb i a
( CAR -BC ) ,
Alber ta
H e a lth S e rv ic e s
(formerly,
Alber ta
A l c o h o l a n d D rug Abuse Comm i s s i o n ) , Man i t oba Hea l t h , th e Cen t r e québeco i s
de
l u t te
a u x d ép en d a n ce s (CQLD) ,
a nd th e C a n a d ia n C e n tre on
Subs t an ce
Abuse ( CCSA ) . Des i g n ed
to
p rov i de a n n u a l na t i o n a l
a nd p ro v i n c i a l e s tim a te s o f a l c o h o l a nd d r ug - r e l a t ed
beha v i o u r s
and
o u t c ome s , CADUMS
was
l a u n c he d in Apr i l 2 0 0 8 .
With in
e ach
y e a r ,
th e
ta rg e te d n u m be r
o f CADUMS i n t e r v i ews
to be
c o n d u c t e d by
t e l e p hone is
1 , 0 0 8 pe r p ro v i n ce ,
ra n d o m ly s e le c te d
to p roduce a
n a tio n a l s u rv e y
o f
1 0 , 0 8 0
in t e rv iew s a n n u a l ly .
Due
to me t h o d o l o g i c a l is su e s, th e territories
a re
n o t in c lu d e d
in
th e s u r v e y .
Prov i n ces
h a v e th e
op t i on to
bu y a d d i tio n a l in t e rv iew s to a l l ow for
more
d e ta ile d a n a ly s is o f
resu l t s
wi th in their
jurisdiction.
Fo r
th e
2 0 1 2
c a le n d a r y e a r,
th e p ro v in c e
o f Bri t ish
C o lu m bia a rra n g ed
for their
s amp l e
to be in cre ase d to 2 ,0 0 8 . Th is r esu l t ed in
a f i n a l
s amp l e o f 1 1 ,0 90 re s po n d e n ts in
2 0 1 2 ,
r ep resen t i ng
app r ox ima t e l y
27,767,855 Cana d i a n s aged 15
an d o l de r . The re spo n se ra te for
th e
2 0 1 2 CADUMS wa s 39 .8 , a de c r e ase fro m 45 .5 in 2 0 1 1 , d ue in
pa r t
to th e
ce ssa t i o n
o f
in t ro d u c t o ry le t te r s
mai l e d
to
po t e n t i a l
r e sponde n t s . Fo r
th e
pu rposes o f th is
re po rt o n ly
un i v a r i a t e
a n d b i va r i a t e
ana l y se s
were
c o n d u c te d , w ith
statistical s i g n i f i c a n c e be ing
de t e rm i n ed
by
con f i d e n ce i n t e r v a l o ve r l a p
for
2 0 1 2 to 2 0 0 4
compa r i s o n s ,
an d t—tes t ing
for
2 0 1 2 to 2 0 1 1
c ompa r i s o n s . The da t a
presen t ed in
th i s
r epo r t
h a v e been
we igh ted
to
a l l ow th e resu l t s
to be
gene ra l i zed
to th e Ca n a d i a n popu l a t i on us i ng th e Ca n a d i a n Census 2 0 1 1 . A t e c h n i c a l gu i de
with
further
de ta i l s
on
th e s urv e y m e th o d o lo g y
wil l
be
ava i l ab l e upon
r eques t
after
Sep t embe r 1 , 2 0 13 .
Fo r
more
i n f o rma t i o n
a b o u t
th e
s u r v e y
an d
it s r esu l t s ,
p lease
wri te to
th e O ff ic e o f R e se arc h a nd
Su r v e i l l a n c e ,
Con t ro l l ed
Subs t an ce s an d Tobacco D i r e c t o r a t e , Hea l t h Ca n a d a , 1 5 0 Tunne y ' s Pas tu re
Dr i veway , A d d re ss Lo c a to r 0 3 0 1 A , Ot t awa ,
ON ,
K1A
0K9 ,
o r
send a n
e -m a i l re qu e st to
C A D UM S -
ESCCAD@hc—sc .gc . c a .
l Ca n a d i a n
Cen t r e
o n
Sub s t a n c e Abuse .
'5 '
Ca n a d a ' s
Low -R i sk
A l co h o l D r in k in q
Gu ide l i nes [brochure],
2 0 1 3 .
A cc es se d M a y 2 4 , 2 0 1 3 .
Date Modified:
2014-04-08
ht tp: / /www.hc-sc.gc.ca /hc-ps/d rugs-drogues/s ta t /_2012/summary-sommaire-eng.php
mailto:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]:[email protected]://www.ccsa.ca/Resource%20Library/2012-Canada-Low-Risk-Alcohol-Drinking-Guidelines-Brochure-en.pdfhttp://www.ccsa.ca/Resource%20Library/2012-Canada-Low-Risk-Alcohol-Drinking-Guidelines-Brochure-en.pdfhttp://www.ccsa.ca/Resource%20Library/2012-Canada-Low-Risk-Alcohol-Drinking-Guidelines-Brochure-en.pdfhttp://www.ccsa.ca/Resource%20Library/2012-Canada-Low-Risk-Alcohol-Drinking-Guidelines-Brochure-en.pdfhttp://www.ccsa.ca/Resource%20Library/2012-Canada-Low-Risk-Alcohol-Drinking-Guidelines-Brochure-en.pdfmailto:[email protected]